Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma

• Catherine Westbom,

  Affiliation Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America

  ⨯
• Joyce K. Thompson,

  Affiliation Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America

  ⨯
• Alan Leggett,

  Affiliation Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America

  ⨯
• Maximilian MacPherson,

  Affiliation Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America

  ⨯
• Stacie Beuschel,

  Affiliation Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America

  ⨯
• Harvey Pass,

  Affiliation Department of Cardiothoracic Surgery, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Pamela Vacek,

  Affiliation Department of Medical Biostatistics, University of Vermont College of Medicine, Burlington, VT, United States of America

  ⨯
• Arti Shukla

  * E-mail: Arti.Shukla@med.uvm.edu

  Affiliation Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America

  ⨯